Editas Medicine
(NASDAQ:EDIT)
$12.95
0.62[5.03%]
At close: Oct 4
$12.95
After Hours: 4:02PM EDT
Day Range12.38 - 12.9552 Wk Range9.59 - 27.99Open / Close12.73 / 12.95Float / Outstanding61.3M / 68.7M
Vol / Avg.1.6M / 1.7MMkt Cap890.1MP/E-50d Avg. Price15.62
Div / Yield-Payout Ratio-Total Float61.3MEPS-0.78

Editas Medicine Stock (NASDAQ:EDIT), Quotes and News Summary

Editas Medicine Stock (NASDAQ: EDIT)

Day Range12.38 - 12.9552 Wk Range9.59 - 27.99Open / Close12.73 / 12.95Float / Outstanding61.3M / 68.7M
Vol / Avg.1.6M / 1.7MMkt Cap890.1MP/E-50d Avg. Price15.62
Div / Yield-Payout Ratio-Total Float61.3MEPS-0.78
Sector: Health Care.Industry: Biotechnology
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-07
REV
Q2 2022Est.ActualSurprise
EPS-0.820-0.780 0.0400
REV4.290M6.362M2.072M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Editas Medicine Questions & Answers

Q
How do I buy Editas Medicine (EDIT) stock?
A

You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Editas Medicine's (EDIT) competitors?
Q
What is the target price for Editas Medicine (EDIT) stock?
A

The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by B of A Securities on Thursday, September 29, 2022. The analyst firm set a price target for 18.00 expecting EDIT to rise to within 12 months (a possible 39.00% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Editas Medicine (EDIT)?
A

The stock price for Editas Medicine (NASDAQ: EDIT) is $12.95 last updated Today at October 4, 2022, 8:00 PM UTC.

Q
Does Editas Medicine (EDIT) pay a dividend?
A

There are no upcoming dividends for Editas Medicine.

Q
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
A

Editas Medicine’s Q3 earnings are confirmed for Monday, November 7, 2022.

Q
Is Editas Medicine (EDIT) going to split?
A

There is no upcoming split for Editas Medicine.

Q
What sector and industry does Editas Medicine (EDIT) operate in?
A

Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.